Sarah Lee, M.D. Hematology/Oncology Fellow at Cleveland Clinic Discusses Daratumumab In A Primary Fractory Population At The 60th ASH Annual Meeting on Dec 1, 2018.
Daratumumab In A Primary Fractory Population
Sarah Lee, M.D. Hematology/Oncology Fellow at Cleveland Clinic Discusses Daratumumab In A Primary Fractory Population At The 60th ASH Annual Meeting on Dec 1, 2018.